Genetic risk factors are involved in the predisposition of individuals to venous thrombosis. These include increased plasma homocysteine levels, which is associated with homozygosity for a nucleotide variant in the methylenetetrahydrofolate reductase (MTHFR) gene. The MTHFR 677 C-T variant (leading to an alanine to valine substitution) results in a thermolabile enzyme and decreased production of folate, which is a cofactor required for homocysteine remethylation. Homozygosity for the MTHFR 677 C-T variant is associated with mild to moderate hyperhomocysteinemia. However, the exact thrombophilic risk conferred by the MTHFR 677 C-T thermolabile variant remains to be defined. Analysis for the MTHFR 677 C-T variant is offered as a specific DNA test, or as part of a Thrombophilia panel which also includes the Factor V Leiden R506Q mutation and the Prothrombin (Factor II) 20210G-A mutation. Reasons For Referral:
Testing Methodology:Direct Mutation Analysis: Our laboratory uses an automated high-throughput system that incorporates DNA amplification (PCR), primer extension, and allele resolution by Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry to test for the 677 C-T variant in the MTHFR gene. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 14
cc; Child: 6
cc; Infant: 2-3 cc Turnaround Time:2 weeks CPT Codes and Prices:83914, 83912, 83898, 83891 Shipping InformationForms:Test Codes:6045 |